Brainomix, a global leader and pioneer of AI-powered imaging tools in lung fibrosis and stroke, today announced it was ...
Jascayd® is the first and only PDE4B inhibitor approved for treating IPF in adults. Jascayd is indicated for the treatment of adults with IPF and PPF. Credit: Boehringer Ingelheim/MultiVu-PR Newswire.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results